HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.

Abstract
Antibiotics blocking bacterial cell wall assembly (beta-lactams and glycopeptides) are facing a challenge from the progressive spread of resistant pathogens. Lantibiotics are promising candidates to alleviate this problem. Microbisporicin, the most potent antibacterial among known comparable lantibiotics, was discovered during a screening applied to uncommon actinomycetes. It is produced by Microbispora sp. as two similarly active and structurally related polypeptides (A1, 2246-Da and A2, 2230-Da) of 24 amino acids linked by 5 intramolecular thioether bridges. Microbisporicin contains two posttranslational modifications that have never been reported previously in lantibiotics: 5-chloro-trypthopan and mono- (in A2) or bis-hydroxylated (in A1) proline. Consistent with screening criteria, microbisporicin selectively blocks peptidoglycan biosynthesis, causing cytoplasmic UDP-linked precursor accumulation. Considering its spectrum of activity and its efficacy in vivo, microbisporicin represents a promising antibiotic to treat emerging infections.
AuthorsFranca Castiglione, Ameriga Lazzarini, Lucia Carrano, Emiliana Corti, Ismaela Ciciliato, Luciano Gastaldo, Paolo Candiani, Daniele Losi, Flavia Marinelli, Enrico Selva, Francesco Parenti
JournalChemistry & biology (Chem Biol) Vol. 15 Issue 1 Pg. 22-31 (Jan 2008) ISSN: 1074-5521 [Print] United States
PMID18215770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Bacteriocins
  • Peptides
  • Peptidoglycan
  • microbisporicin
  • Tryptophan
  • Proline
Topics
  • Actinomycetales (chemistry, drug effects, metabolism)
  • Amino Acid Sequence
  • Anti-Bacterial Agents (chemistry, pharmacology)
  • Bacteriocins (chemistry, pharmacology)
  • Drug Resistance, Multiple, Bacterial (drug effects, physiology)
  • Molecular Sequence Data
  • Peptides (chemistry, pharmacology)
  • Peptidoglycan (biosynthesis)
  • Proline (analogs & derivatives, pharmacology)
  • Tryptophan (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: